J Oldenburg
Overview
Explore the profile of J Oldenburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
2501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eichler H, Albisetti M, Halimeh S, Knofler R, Konigs C, Langer F, et al.
Hamostaseologie
. 2024 Dec;
PMID: 39631753
Since the 1970s, specialized hemophilia centers have been established to optimize the complex and costly treatment of patients with severe bleeding disorders. In 2019, the first GTH guidelines on the...
2.
Ivaskevicius V, Biswas A, Singh S, Stulpinaite U, Reda S, Ruhl H, et al.
Hamostaseologie
. 2023 Jul;
43(6):440-446.
PMID: 37442158
Introduction: Inherited dysfibrinogenemia is a qualitative defect of fibrinogen caused by various mutations among three fibrinogen genes. Dysfibrinogenemia can be associated with an increased risk of thrombosis, bleeding, or both....
3.
Pezeshkpoor B, Oldenburg J, Pavlova A
Hamostaseologie
. 2022 Feb;
42(S 01):S5-S12.
PMID: 35226963
Hemostasis is a complex and tightly regulated system that attempts to maintain a homeostatic balance to permit normal blood flow, without bleeding or thrombosis. Hemostasis reflects the subtle balance between...
4.
Oldenburg J, Berney D, Bokemeyer C, Climent M, Daugaard G, Gietema J, et al.
Ann Oncol
. 2022 Jan;
33(4):362-375.
PMID: 35065204
No abstract available.
5.
Aeppli S, Schmaus M, Eisen T, Escudier B, Grunwald V, Larkin J, et al.
ESMO Open
. 2021 Jan;
6(1):100030.
PMID: 33460963
Background: The treatment landscape of metastatic clear cell renal cell carcinoma (mccRCC) has been transformed by targeted therapies with tyrosine kinase inhibitors (TKI) and more recently by the incorporation of...
6.
Horwich A, Babjuk M, Bellmunt J, Bruins H, de Reijke T, De Santis M, et al.
Ann Oncol
. 2019 Nov;
30(11):1697-1727.
PMID: 31740927
Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Objective: To bring together a large multidisciplinary...
7.
Bauersachs R, Schellong S, Stucker M, Oldenburg J, Kalka C, Scholz U, et al.
Hamostaseologie
. 2019 Aug;
39(3):298-300.
PMID: 31404932
No abstract available.
8.
Pezeshkpoor B, Gazorpak M, Berkemeier A, Singer H, Pavlova A, Biswas A, et al.
Ann Hematol
. 2019 Apr;
98(8):1855-1865.
PMID: 30997536
Haemophilia A (HA) is caused by a lack or reduced amount of factor VIII protein (FVIII). About one-third of patients with non-severe HA carrying specific missense mutations show discrepant results...
9.
Buerfent B, Golz L, Hofmann A, Ruhl H, Stamminger W, Fricker N, et al.
Sci Rep
. 2019 Feb;
9(1):2562.
PMID: 30796272
Filarial nematodes modulate immune responses in their host to enable their survival and mediate protective effects against autoimmunity and allergies. In this study, we examined the immunomodulatory capacity of extracts...
10.
Banchev A, Goldmann G, Marquardt N, Klein C, Horneff S, Langenkamp R, et al.
Hamostaseologie
. 2019 Jan;
39(4):347-354.
PMID: 30654393
Background: Record keeping is integral to home treatment for haemophilia. Issues with paper diaries include questionable compliance, data validity and quality. Implementation of electronic diaries (e-diaries) in haemophilia patients could...